41
Views
3
CrossRef citations to date
0
Altmetric
Original

Tipping the balance towards tolerance: The basis for therapeutic immune modulation by gold?

, , &
Pages 393-397 | Received 09 May 2005, Accepted 31 May 2005, Published online: 07 Jul 2009
 

Abstract

Gold salts have long been used in the treatment of rheumatoid arthritis. However, the basis for their therapeutic immune-modulating properties has never been satisfactorily explained. Furthermore, treatments are often marred by the development of adverse immune reactions such as hypersensitivity and even exacerbation of autoimmunity. We would like to propose a hypothesis to explain the basis for both the beneficial and adverse immune-modulating effects of gold in the treatment of rheumatoid arthritis. If accepted, this hypothesis will allow for the development of safer and more effective treatments with gold salts. The principle underlying this hypothesis also has broader implications for how immune hypersensitivity and tolerance are perceived.

Acknowledgements

Supported by the Higher Education Authority (HEA) of Ireland under the Programme for Research in Third Level Institutions Cycle 2 (HEA PRTLI 2), as part of the National Development Plan. The authors gratefully acknowledge Shailendra Anoopkumar-Dukie, David Groeger, Peter O'Keeffe and the staff of the Biological Services Unit, UCC for their technical support.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.